Professor Weihong Tan earned his Ph.D. in physical chemistry at the University of Michigan in 1993. Currently, he is the director of the State Key Laboratory of Chemo/Biosensing and Chemometrics, and distinguished professor of chemistry and biology at Hunan University. He is also the director of the Institute of Basic Medicine and Cancer, Chinese Academy of Sciences; the dean of the Cancer Hospital of the University of Chinese Academy of Sciences; and the director of the Institute of Molecular Medicine at Renji Hospital and Shanghai Jiao Tong University. Furthermore he served as a Distinguished Professor and a V.T. and Louis Jackson Professor at the University of Florida for more than 20 years.
Professor Tan’s research is in the general area of bioanalytical chemistry, molecular medicine and chemical biology. He specializes in aptamer research, DNA nanotechnology, and cancer theranostics. He has published over 750 peer-reviewed scientific papers. According to Thomson Reuters, he is among the small, prestigious group of Highly Cited Researchers for the period between 2014-2020. The total citations of his publications exceed 69,000 with an H index of 146. He served as an associate editor for JACS (Journal of American Chemical Society) and is currently an associate editor for CCS Chemistry. He has received over thirty awards and honors, including the Beckman Young Investigator Award in 1997, the Pittcon Achievement Award in 2004, the AAAS Fellow in 2005, the ACS Florida Award in 2012, the Award in Spectrochemical Analysis from the American Chemical Society in 2018, the Prize for Scientific and Technological Progress, Ho Leung Ho Lee Foundation in 2018, the Ralph Adams Award for Bioanalytical chemistry in 2019 and The Pittsburgh Analytical Chemistry Award in 2019. Professor Tan has also been recognized as an Academician of the Chinese Academy of Sciences in 2015, Academician of the World Academy of Sciences in Developing Countries in 2016, and Member of the European Academy of Science in 2019.